Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Tumor Treating Fields : Additional Mechanisms and Additional Applications

  • Received : 2020.06.27
  • Accepted : 2020.08.20
  • Published : 2021.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Badawy RA, Strigaro G, Cantello R : TMS, cortical excitability and epilepsy: the clinical impact. Epilepsy Res 108 : 153-161, 2014 https://doi.org/10.1016/j.eplepsyres.2013.11.014
  2. D'Amico RS, Englander ZK, Canoll P, Bruce JN : Extent of resection in glioma-a review of the cutting edge. World Neurosurg 103 : 538-549, 2017 https://doi.org/10.1016/j.wneu.2017.04.041
  3. Davies AM, Weinberg U, Palti Y : Tumor treating fields: a new frontier in cancer therapy. Ann N Y Acad Sci 1291 : 86-95, 2013 https://doi.org/10.1111/nyas.12112
  4. Hervey-Jumper SL, Berger MS : Evidence for improving outcome through extent of resection. Neurosurg Clin N Am 30 : 85-93, 2019 https://doi.org/10.1016/j.nec.2018.08.005
  5. Hervey-Jumper SL, Berger MS : Maximizing safe resection of low- and high-grade glioma. J Neurooncol 130 : 269-282, 2016 https://doi.org/10.1007/s11060-016-2110-4
  6. Kanner AA, Wong ET, Villano JL, Ram Z; EF-11 Investigators : Post hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100ATM system versus best physician's choice chemotherapy. Semin Oncol 41(Suppl 6) : S25-S34, 2014 https://doi.org/10.1053/j.seminoncol.2014.09.008
  7. Kusne Y, Sanai N : The SVZ and its relationship to stem cell based neuro-oncogenesis. Adv Exp Med Biol 853 : 23-32, 2015 https://doi.org/10.1007/978-3-319-16537-0_2
  8. Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, et al. : Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 560 : 243-247, 2018 https://doi.org/10.1038/s41586-018-0389-3
  9. Sanai N, Alvarez-Buylla A, Berger MS : Neural stem cells and the origin of gliomas. N Engl J Med 353 : 811-822, 2005 https://doi.org/10.1056/NEJMra043666
  10. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. : Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 : 987-996, 2005 https://doi.org/10.1056/NEJMoa043330
  11. Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, et al. : Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318 : 2306-2316, 2017 https://doi.org/10.1001/jama.2017.18718
  12. Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, et al. : NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 48 : 2192-2202, 2012. https://doi.org/10.1016/j.ejca.2012.04.011
  13. Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. : Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA 314 : 2535-2543, 2015 https://doi.org/10.1001/jama.2015.16669
  14. Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, et al. : Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23 : 1985-1996, 2014 https://doi.org/10.1158/1055-9965.EPI-14-0275
  15. Toda H, Hamani C, Fawcett AP, Hutchison WD, Lozano AM : The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation. J Neurosurg 108 : 132-138, 2008 https://doi.org/10.3171/JNS/2008/108/01/0132
  16. Venkataramani V, Tanev DI, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T, et al. : Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature 573 : 532-538, 2019 https://doi.org/10.1038/s41586-019-1564-x
  17. Venkatesh H, Monje M : Neuronal activity in ontogeny and oncology. Trends Cancer 3 : 89-112, 2017 https://doi.org/10.1016/j.trecan.2016.12.008
  18. Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S, et al. : Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell 161 : 803-816, 2015 https://doi.org/10.1016/j.cell.2015.04.012
  19. Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, et al. : Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature 549 : 533-537, 2017 https://doi.org/10.1038/nature24014
  20. Venkatesh HS, Morishita W, Geraghty AC, Silverbush D, Gillespie SM, Arzt M, et al. : Electrical and synaptic integration of glioma into neural circuits. Nature 573 : 539-545, 2019 https://doi.org/10.1038/s41586-019-1563-y
  21. Zeng Q, Michael IP, Zhang P, Saghafinia S, Knott G, Jiao W, et al. : Synaptic proximity enables NMDAR signalling to promote brain metastasis. Nature 573 : 526-531, 2019 https://doi.org/10.1038/s41586-019-1576-6
  22. Zhang C, Du J, Xu W, Huang H, Gao L : The value of tumor treating fields in glioblastoma. J Korean Neurosurg Soc 63 : 681-688, 2020 https://doi.org/10.3340/jkns.2019.0224